AbCellera Biologics (ABCL) EBIT Margin (2020 - 2026)
AbCellera Biologics (ABCL) posted EBIT Margin of -1550.05% for Q2 2026, down 1259.81 percentage points from -290.24% a year earlier and down 858.30 percentage points from the prior quarter.
Powered by 
Analysis
AbCellera Biologics (ABCL) EBIT Margin (2020 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, EBIT Margin at AbCellera Biologics was -340.25%, up 507.36 percentage points year-over-year; for FY2025, it was -288.98%, up 802.71 percentage points from FY2024.
- Annual EBIT Margin shows a five-year change of -355.90 percentage points (FY2020 to FY2025).
- In prior years, AbCellera Biologics' EBIT Margin was -1091.69% in FY2024 (-467.87 pp), -623.82% in FY2023 (-668.42 pp), 44.60% in FY2022 (-9.88 pp) and 54.48% in FY2021 (-12.44 pp).
- The Q2 2026 figure stands as the lowest quarterly EBIT Margin in data going back to Q1 2020.
- On a year-over-year basis, EBIT Margin increased in four of the last eight quarters, with an average year-over-year change of +27.72 percentage points.
- The strongest year-over-year quarter for EBIT Margin in the past five years was Q4 2025, with a gain of 1376.97 percentage points; the weakest was Q2 2026, with a drop of 1259.81 percentage points.
- According to Business Quant data, EBIT Margin for the three prior quarters was -691.75% (Q1 2026), -63.72% (Q4 2025) and -851.79% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 653.54 Bn | 572.07 Bn | 17.26 Bn | 28.21% |
| 2 | AbbVie | 467.01 Bn | 440.17 Bn | 12.70 Bn | 37.86% |
| 3 | Merck | 367.16 Bn | 321.59 Bn | 12.21 Bn | -3.52% |
| 4 | Novartis Ag | 277.56 Bn | 233.43 Bn | 11.24 Bn | 32.97% |
| 5 | Astrazeneca | 258.23 Bn | 231.79 Bn | 12.86 Bn | 20.57% |
| 6 | Amgen | 224.14 Bn | 179.54 Bn | 7.24 Bn | 34.95% |
| 7 | Gilead Sciences | 187.30 Bn | 161.42 Bn | 6.22 Bn | -133.21% |
| 8 | Pfizer | 163.47 Bn | 110.41 Bn | 10.94 Bn | 28.37% |
| 9 | Vertex Pharmaceuticals | 133.31 Bn | 105.31 Bn | 2.84 Bn | 37.40% |
| 10 | AbCellera Biologics | 3.89 Bn | 3.89 Bn | - | -1,550.05% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -1,550.05% |
| Mar 31, 2026 | -691.75% |
| Dec 31, 2025 | -63.72% |
| Sep 30, 2025 | -851.79% |
| Jun 30, 2025 | -290.24% |
| Mar 31, 2025 | -1,479.57% |
| Dec 31, 2024 | -1,440.69% |
| Sep 30, 2024 | -1,439.42% |
| Jun 30, 2024 | -1,276.17% |
| Mar 31, 2024 | -551.48% |
| Dec 31, 2023 | -719.61% |
| Sep 30, 2023 | -831.79% |
| Jun 30, 2023 | -511.03% |
| Mar 31, 2023 | -532.10% |
| Dec 31, 2022 | -175.34% |
| Sep 30, 2022 | 37.22% |
| Jun 30, 2022 | -18.29% |
| Mar 31, 2022 | 71.06% |
| Dec 31, 2021 | 58.53% |
| Sep 30, 2021 | -510.09% |
API Access
AbCellera Biologics EBIT Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebit-margin&ticker=ABCL&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebit-margin", "ticker": "ABCL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebit-margin&ticker=ABCL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();